See more : Mitsui DM Sugar Holdings Co.,Ltd. (2109.T) Income Statement Analysis – Financial Results
Complete financial analysis of Zepp Health Corporation (ZEPP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Zepp Health Corporation, a leading company in the Consumer Electronics industry within the Technology sector.
- Xi’an Typical Industries Co.,Ltd (600302.SS) Income Statement Analysis – Financial Results
- China Growth Development, Inc. (CGDI) Income Statement Analysis – Financial Results
- Ameren Illinois Company (AILLN) Income Statement Analysis – Financial Results
- Mission Advancement Corp. (MACC-UN) Income Statement Analysis – Financial Results
- Sparinvest SICAV – Ethical Global Value (SSIEGVEURR.CO) Income Statement Analysis – Financial Results
Zepp Health Corporation (ZEPP)
About Zepp Health Corporation
Zepp Health Corporation, together with its subsidiaries, develops, manufactures, and sells smart wearable technological devices in the People's Republic of China. It operates through two segments, Xiaomi Wearable Products, and Self-Branded Products and Others. The company offers smart bands, watches, and scales; and smart hearable products, home treadmill, sportswear, home appliances, and smart watch accessories under the Xiaomi and Amazfit brands. It provides charts and graphs to display analysis of the activity and biometric data collected from users through its Zepp Life and Zepp mobile apps. The company was formerly known as Huami Corporation and changed its name to Zepp Health Corporation in February 2021. Zepp Health Corporation was founded in 2013 and is headquartered in Hefei, the People's Republic of China.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 2.50B | 4.14B | 6.25B | 6.43B | 5.81B | 3.65B | 2.05B | 1.56B | 896.46M |
Cost of Revenue | 1.84B | 3.34B | 4.94B | 5.10B | 4.34B | 2.71B | 1.55B | 1.28B | 785.87M |
Gross Profit | 657.78M | 803.12M | 1.31B | 1.33B | 1.47B | 939.45M | 494.70M | 276.15M | 110.59M |
Gross Profit Ratio | 26.36% | 19.39% | 20.89% | 20.71% | 25.25% | 25.77% | 24.14% | 17.74% | 12.34% |
Research & Development | 361.81M | 517.12M | 515.08M | 538.01M | 430.82M | 263.22M | 153.83M | 132.30M | 61.55M |
General & Administrative | 188.51M | 235.93M | 258.35M | 261.81M | 248.46M | 213.97M | 114.88M | 102.64M | 69.98M |
Selling & Marketing | 314.56M | 460.30M | 438.27M | 358.66M | 181.98M | 96.54M | 44.03M | 27.82M | 19.17M |
SG&A | 503.07M | 696.24M | 696.62M | 620.46M | 430.44M | 310.51M | 158.91M | 130.47M | 89.15M |
Other Expenses | 0.00 | 43.82M | 40.93M | -23.55M | 10.59M | 1.18M | 4.56M | 14.73M | 1.11M |
Operating Expenses | 864.88M | 1.21B | 1.21B | 1.16B | 861.26M | 573.73M | 312.73M | 262.77M | 150.71M |
Cost & Expenses | 2.70B | 4.55B | 6.16B | 6.26B | 5.21B | 3.28B | 1.87B | 1.54B | 936.57M |
Interest Income | 3.09M | 12.33M | 16.69M | 46.12M | 33.48M | 11.60M | 3.00M | 754.00K | 255.00K |
Interest Expense | 6.73M | 57.00M | 44.88M | 22.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 7.68M | 58.62M | 51.88M | 27.13M | 17.22M | 6.22M | 3.72M | 2.40M | 285.00K |
EBITDA | -134.39M | -354.09M | 93.94M | 105.35M | 623.70M | 357.60M | 185.69M | 15.78M | -39.83M |
EBITDA Ratio | -5.39% | -8.55% | 2.42% | 1.64% | 10.40% | 9.81% | 8.77% | 1.01% | -4.44% |
Operating Income | -207.10M | -410.24M | 93.94M | 78.22M | 606.48M | 365.72M | 181.97M | 13.38M | -40.11M |
Operating Income Ratio | -8.30% | -9.90% | 1.50% | 1.22% | 10.43% | 10.03% | 8.88% | 0.86% | -4.47% |
Total Other Income/Expenses | 173.70M | 356.25M | -77.21M | -37.57M | -513.25M | -309.52M | -152.58M | 15.48M | 1.36M |
Income Before Tax | -33.40M | -372.53M | 106.67M | 265.61M | 652.37M | 386.61M | 191.90M | 28.86M | -38.75M |
Income Before Tax Ratio | -1.34% | -8.99% | 1.71% | 4.13% | 11.22% | 10.61% | 9.37% | 1.85% | -4.32% |
Income Tax Expense | -2.23M | -65.88M | 10.75M | 31.15M | 77.89M | 52.04M | 27.61M | 3.09M | -897.00K |
Net Income | -212.12M | -306.66M | 95.92M | 228.75M | 575.20M | 340.05M | 167.68M | 23.95M | -37.85M |
Net Income Ratio | -8.50% | -7.40% | 1.53% | 3.56% | 9.90% | 9.33% | 8.18% | 1.54% | -4.22% |
EPS | -13.96 | -4.98 | 1.52 | 3.68 | 9.44 | 6.08 | 0.78 | -0.20 | -0.64 |
EPS Diluted | -13.96 | -4.98 | 1.45 | 3.51 | 8.99 | 6.04 | 0.78 | -0.20 | -0.64 |
Weighted Avg Shares Out | 15.20M | 61.57M | 63.04M | 62.12M | 60.91M | 55.94M | 59.43M | 59.43M | 59.43M |
Weighted Avg Shares Out (Dil) | 15.20M | 61.57M | 66.09M | 65.09M | 63.99M | 56.26M | 59.43M | 59.43M | 59.43M |
Zepp Health Corporation to Report Second Quarter 2023 Financial Results on August 21, 2023
Polish Running Icon Edyta Lewandowska Joins Amazfit as Brand Ambassador for UTMB 2023
AMAZFIT TEAMS UP WITH ULTRA-MARATHON LEGENED DEAN KARNAZES FOR THE LAUNCH OF AMAZFIT CHEETAH PRO
Zepp Health Corporation (ZEPP) Q1 2023 Earnings Call Transcript
NEW AMAZFIT GTR MINI IS UNVEILED, PACKING MAX POWER & STYLE INTO A SLIM & LIGHT ROUND SMARTWATCH
Zepp Health Corporation (ZEPP) Q3 2022 Earnings Call Transcript
Amazfit GTR 4 & GTS 4 Now Compatible with adidas Running
Zepp Health (ZEPP) Stock: Why It Fell 3.85%
Zepp Health Corporation (ZEPP) Q2 2022 Earnings Call Transcript
Zepp: Speculative, But With Potentially Great Rewards
Source: https://incomestatements.info
Category: Stock Reports
What are the key factors affecting Zepp Health’s financial performance?
A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the cooperation with Xiaomi, the recognition of the Company’s self-branded products; the Company’s growth strategies; trends and competition in global …